Cancer research

GSK and Oxford University Collaborate on Cancer Vaccines

GSK and the University of Oxford have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The program, in which GSK plans to invest up to £50 million over a minimum of three years, will conduct translational research, exploring precancer biology to generate key insights on how cancer develops in humans that could inform future development of cancer vaccines.

Boehringer Ingelheim Expands Cancer Research at Vienna Site

On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.

Merck KGaA and iOnctura in new JV

Cancer Research UK and HitGen in Pact

Tusk in UK Cancer Collaboration

UK Groups Plan Life Sciences Investment Firm

Sanofi Seals two Oncology Partnerships

AstraZeneca Signs Up First Cambridge Partners In Cancer Research

Britain to Fund Prostate Cancer Pill in U-turn

Genome Study Brings Blood Cancer Into Sharp Focus